Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs.
AUTOR(ES)
Little, S F
RESUMO
The protective effects of polyclonal antisera produced by injecting guinea pigs with protective antigen (PA), the chemical anthrax vaccine AVA, or Sterne spore vaccine, as well as those of toxin-neutralizing monoclonal antibodies (MAbs) produced against PA, lethal factor, and edema factor, were examined in animals infected with Bacillus anthracis spores. Only the anti-PA polyclonal serum significantly protected the guinea pigs from death, with 67% of infected animals surviving. Although none of the MAbs was protective, one PA MAb caused a significant delay in time to death. Our findings demonstrate that antibodies produced against only PA can provide passive protection against anthrax infection in guinea pigs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175745Documentos Relacionados
- Efficiency of Protection of Guinea Pigs against Infection with Bacillus anthracis Spores by Passive Immunization
- Effect of passive immunization with purified specific or cross-reacting immunoglobulin G antibodies against Treponema pallidum on the course of infection in guinea pigs.
- Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy.
- Vaccination against Legionella pneumophila: serum antibody correlates with protection induced by heat-killed or acetone-killed cells against intraperitoneal but not aerosol infection in guinea pigs.
- Pathogenesis of Lassa virus infection in guinea pigs.
